Please provide us with a few details so that we can match you with the right expert in your field.
*Required
Our DMPK experts help steer your project to success with a clear insight into the pharmacokinetics of your therapeutic. The team develop impactful in vivo PK studies before generating and interpreting data that helps you make informed decisions about the next stage of your project.
Quick and simple, our Discovery option aims to generate robust data using generic, tried-and-tested methodologies to quantify your compound and provide rapid, informative data on which decisions can be made. This tier involves no commitment to method development, making it ideal as a follow-on from our PK screening option, or for compounds from familiar chemical series likely to run well under industry-standard bioanalytical conditions. With our Discovery offering, we minimize costs while maintaining our characteristic exacting standards, enabling you to submit more compounds in less time, accelerating lead identification efficiently and affordably. Reporting options are available, from simple data tables to formal written data reports, with the flexibility to tailor documents to your requirements.
Find out how we can help you rapidly evaluate the PK of your therapeutic and have a confidential discussion with our experts about your project needs.